Evidence-Based Reviews

Switching antipsychotics: A balanced approach to ease the transition

Author and Disclosure Information

 

References

All groups improved slightly on the Barnes Akathisia Scale, Simpson Angus Rating Scale, and Abnormal Involuntary Movement Scale. Few patients in each group required benztropine (2%, 4%, and 7% for groups 1, 2 and 3, respectively).

Related resources

  • Borison RL. Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing. Clin Ther 1996;18(4):592-607.

Drug brand names

  • Aripiprazole • Abilify
  • Benztropine • Cogentin
  • Chlorpromazine • Thorazine
  • Clozapine • Clozaril
  • Fluphenazine • Prolixin
  • Haloperidol • Haldol
  • Olanzapine • Zyprexa
  • Quetiapine • Seroquel
  • Risperidone • Risperdal
  • Ziprasidone • Geodon

Disclosure

Dr. Winans is a consultant for Bristol-Myers Squibb Co. and is a speaker for Pfizer Inc., Abbott Laboratories, and Bristol-Myers Squibb Co.

Pages

Recommended Reading

UPDATE ON ATYPICALS: Practical tips to manage common side effects
MDedge Psychiatry
Treating persistent psychosis with cognitive-behavioral therapy
MDedge Psychiatry
UPDATE ON ATYPICALS: Preemptive tactics to reduce weight gain
MDedge Psychiatry
First-episode psychosis: our greatest challenge
MDedge Psychiatry
Aripiprazole: What the researchers say
MDedge Psychiatry
First psychotic episode—a window of opportunity: Seize the moment to build a therapeutic alliance
MDedge Psychiatry
Treating schizophrenia in the ‘real world’
MDedge Psychiatry
How to avoid ethnic bias when diagnosing schizophrenia
MDedge Psychiatry
Irritable bowel syndrome and psychiatric illness: Three clinical challenges
MDedge Psychiatry
Taking the ‘ouch’ out of IM antipsychotics
MDedge Psychiatry